• Something wrong with this record ?

Convergence, plasticity, and tissue residence of regulatory T cell response via TCR repertoire prism

TO. Nakonechnaya, B. Moltedo, EV. Putintseva, S. Leyn, DA. Bolotin, OV. Britanova, M. Shugay, DM. Chudakov

. 2024 ; 12 (-) : . [pub] 20240409

Language English Country England, Great Britain

Document type Journal Article

Grant support
P30 CA008748 NCI NIH HHS - United States
075-15-2019-1789 Ministry of Science and Higher Education of the Russian Federation

Suppressive function of regulatory T cells (Treg) is dependent on signaling of their antigen receptors triggered by cognate self, dietary, or microbial peptides presented on MHC II. However, it remains largely unknown whether distinct or shared repertoires of Treg TCRs are mobilized in response to different challenges in the same tissue or the same challenge in different tissues. Here we use a fixed TCRβ chain FoxP3-GFP mouse model to analyze conventional (eCD4) and regulatory (eTreg) effector TCRα repertoires in response to six distinct antigenic challenges to the lung and skin. This model shows highly 'digital' repertoire behavior with easy-to-track challenge-specific TCRα CDR3 clusters. For both eCD4 and eTreg subsets, we observe challenge-specific clonal expansions yielding homologous TCRα clusters within and across animals and exposure sites, which are also reflected in the draining lymph nodes but not systemically. Some CDR3 clusters are shared across cancer challenges, suggesting a response to common tumor-associated antigens. For most challenges, eCD4 and eTreg clonal response does not overlap. Such overlap is exclusively observed at the sites of certain tumor challenges, and not systematically, suggesting transient and local tumor-induced eCD4=>eTreg plasticity. This transition includes a dominant tumor-responding eCD4 CDR3 motif, as well as characteristic iNKT TCRα CDR3. In addition, we examine the homeostatic tissue residency of clonal eTreg populations by excluding the site of challenge from our analysis. We demonstrate that distinct CDR3 motifs are characteristic of eTreg cells residing in particular lymphatic tissues, regardless of the challenge. This observation reveals the tissue-resident, antigen-specific clonal Treg populations.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014348
003      
CZ-PrNML
005      
20240905134255.0
007      
ta
008      
240725e20240409enk f 000 0|eng||
009      
AR
024    7_
$a 10.7554/eLife.89382 $2 doi
035    __
$a (PubMed)38591522
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Nakonechnaya, Tatyana O $u Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russian Federation $u Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation
245    10
$a Convergence, plasticity, and tissue residence of regulatory T cell response via TCR repertoire prism / $c TO. Nakonechnaya, B. Moltedo, EV. Putintseva, S. Leyn, DA. Bolotin, OV. Britanova, M. Shugay, DM. Chudakov
520    9_
$a Suppressive function of regulatory T cells (Treg) is dependent on signaling of their antigen receptors triggered by cognate self, dietary, or microbial peptides presented on MHC II. However, it remains largely unknown whether distinct or shared repertoires of Treg TCRs are mobilized in response to different challenges in the same tissue or the same challenge in different tissues. Here we use a fixed TCRβ chain FoxP3-GFP mouse model to analyze conventional (eCD4) and regulatory (eTreg) effector TCRα repertoires in response to six distinct antigenic challenges to the lung and skin. This model shows highly 'digital' repertoire behavior with easy-to-track challenge-specific TCRα CDR3 clusters. For both eCD4 and eTreg subsets, we observe challenge-specific clonal expansions yielding homologous TCRα clusters within and across animals and exposure sites, which are also reflected in the draining lymph nodes but not systemically. Some CDR3 clusters are shared across cancer challenges, suggesting a response to common tumor-associated antigens. For most challenges, eCD4 and eTreg clonal response does not overlap. Such overlap is exclusively observed at the sites of certain tumor challenges, and not systematically, suggesting transient and local tumor-induced eCD4=>eTreg plasticity. This transition includes a dominant tumor-responding eCD4 CDR3 motif, as well as characteristic iNKT TCRα CDR3. In addition, we examine the homeostatic tissue residency of clonal eTreg populations by excluding the site of challenge from our analysis. We demonstrate that distinct CDR3 motifs are characteristic of eTreg cells residing in particular lymphatic tissues, regardless of the challenge. This observation reveals the tissue-resident, antigen-specific clonal Treg populations.
650    _2
$a myši $7 D051379
650    _2
$a zvířata $7 D000818
650    12
$a regulační T-lymfocyty $7 D050378
650    12
$a CD4-pozitivní T-lymfocyty $7 D015496
650    _2
$a receptory antigenů T-buněk $x genetika $7 D011948
650    _2
$a peptidy $7 D010455
650    _2
$a buněčné klony $7 D002999
655    _2
$a časopisecké články $7 D016428
700    1_
$a Moltedo, Bruno $u Howard Hughes Medical Institute and Immunology Program, Sloan Kettering Institute and Ludwig Center at Memorial Sloan Kettering Cancer Center, New York, United States
700    1_
$a Putintseva, Ekaterina V $u Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation
700    1_
$a Leyn, Sofya $u Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation
700    1_
$a Bolotin, Dmitry A $u Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russian Federation $u Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation
700    1_
$a Britanova, Olga V $u Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russian Federation $u Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation $1 https://orcid.org/0000000262951392
700    1_
$a Shugay, Mikhail $u Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russian Federation $u Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation $1 https://orcid.org/0000000178267942
700    1_
$a Chudakov, Dmitriy M $u Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russian Federation $u Genomics of Adaptive Immunity Department, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russian Federation $u Central European Institute of Technology, Brno, Czech Republic $u Abu Dhabi Stem Cells Center, Abu Dhabi, United Arab Emirates $1 https://orcid.org/000000030430790X
773    0_
$w MED00188753 $t eLife $x 2050-084X $g Roč. 12 (20240409)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38591522 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134249 $b ABA008
999    __
$a ok $b bmc $g 2143868 $s 1226214
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 12 $c - $e 20240409 $i 2050-084X $m eLife $n Elife $x MED00188753
GRA    __
$a P30 CA008748 $p NCI NIH HHS $2 United States
GRA    __
$a 075-15-2019-1789 $p Ministry of Science and Higher Education of the Russian Federation
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...